Celgene CorpAdd to My Watchlist

CELG:USNASDAQ GSIndustry: Medical-Biomedical/Gene
  • 121.53
    Last
  • 1.82  -1.48%
    Today's Change
  • 123.35
    Previous Close
  • Today
     
    66.85
    125.45
    52 Week Low - High
8:10 pm ET 2/27/2015
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding801 million
Market Cap$97 billion
Return on Equity ttm33.02%
Last DividendCELG:US does not pay a dividend
Earnings
EPS: Year Actual ttm2.558
EPS: Year Est. 12/15 ttm4.808
 
EPS: Quarterly Actual 12/14 1.01
EPS: Quarterly Est. 3/15 1.07
 
Price/Earnings ttm47.51
Relative Price/Earnings2.722
Earnings Growth Rate42.29
Company Description
Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.
Revenue$8 billion
Net Income$2 billion
Total Assets$17 billion
Employees6,012
Web Sitewww.celgene.com

Latest Headlines

Watchlist

Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

Sign In Now

 

Not Registered?

Get complete access to The Washington Post online - it's FREE!